Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study

Emilia A Hermann; Benjamin Lee; Pallavi P Balte; Vanessa Xanthakis; Beth D Kirkpatrick; Mary Cushman; Elizabeth Oelsner

doi:10.1001/jamanetworkopen.2022.37908

Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study

JAMA Netw Open. 2022 Oct 3;5(10):e2237908. doi: 10.1001/jamanetworkopen.2022.37908.

Authors

Emilia A Hermann¹, Benjamin Lee², Pallavi P Balte¹, Vanessa Xanthakis^{3

4}, Beth D Kirkpatrick^{5

6}, Mary Cushman⁵, Elizabeth Oelsner¹

Affiliations

¹ Division of General Medicine, Department of Medicine, Columbia University, New York, New York.
² Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington.
³ Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
⁴ Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
⁵ Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington.
⁶ Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont, Burlington.

No abstract available

Plain language summary

This cohort study examines the association of self-reported postvaccination symptoms with anti–SARS-CoV-2 antibody response among Framingham Heart Study participants contributing to the Collaborative Cohort of Cohorts for COVID-19 Research study.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Antibodies, Viral
Antibody Formation
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Vaccination

Substances

COVID-19 Vaccines
Antibodies, Viral

Grants and funding

R21 HL165405/HL/NHLBI NIH HHS/United States